| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Schepens Eye Research Institute, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts.
PURPOSE. Tissues derived from immune-privileged sites sometimes possess special characteristics that promote their own survival when transplanted to a nonprivileged site. This study was undertaken to evaluate whether retinal pigment epithelium (RPE) behaves as an immune-privileged tissue when transplanted extraocularly.
METHODS. RPE grafts were prepared from eyes of neonatal C57BL/6 or C57BL/6 gld/gld (deficient in CD95 ligand expression) mice. These grafts (or conjunctival grafts as positive controls) were transplanted into the anterior chamber, the subretinal space, the subconjunctival space, and underneath the kidney capsule of histoincompatible BALB/c mice. Transplant survival was evaluated by histology at selected time points after engraftment. Recipients were tested for acquisition of C57BL/6-specific delayed-type hypersensitivity (DH) and for the ability to suppress DH.
RESULTS. Allogeneic neonatal RPE grafts from normal donors showed significantly enhanced survival at all graft sites compared with conjunctival grafts. However, allogeneic RPE cell grafts from gld/gld mice were rapidly rejected after transplantation beneath the kidney capsule. Allogeneic RPE grafts placed in extraocular sites induced systemic DH directed at donor alloantigens, whereas RPE allografts placed intraocularly induced suppression of systemic DH.
CONCLUSIONS. Allogeneic neonatal RPE grafts, through constitutive expression of CD95 ligand, promote their own survival at heterotopic sites. Paradoxically, these grafts also display immunogenicity. Thus, neonatal RPE tissue owes its immune privilege to the capacity to prevent immune rejection rather than to inhibit sensitization.
This article has been cited by other articles:
|
|
 |
|
  S. Sugita, S. Horie, O. Nakamura, Y. Futagami, H. Takase, H. Keino, H. Aburatani, N. Katunuma, K. Ishidoh, Y. Yamamoto, et al. Retinal Pigment Epithelium-Derived CTLA-2{alpha} Induces TGF{beta}-Producing T Regulatory Cells J. Immunol., December 1, 2008; 181(11): 7525 - 7536. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Futagami, S. Sugita, J. Vega, K. Ishida, H. Takase, K. Maruyama, H. Aburatani, and M. Mochizuki Role of Thrombospondin-1 in T Cell Response to Ocular Pigment Epithelial Cells J. Immunol., June 1, 2007; 178(11): 6994 - 7005. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sugita, H. Keino, Y. Futagami, H. Takase, M. Mochizuki, J. Stein-Streilein, and J. W. Streilein B7+ Iris Pigment Epithelial Cells Convert T Cells into CTLA-4+, B7-Expressing CD8+ Regulatory T Cells Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5376 - 5384. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Cai, M. C. Shin, T. H. Tezel, H. J. Kaplan, and L. V. Del Priore Use of iris pigment epithelium to replace retinal pigment epithelium in age-related macular degeneration: a gene expression analysis. Arch Ophthalmol, September 1, 2006; 124(9): 1276 - 1285. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Semkova, S. Fauser, A. Lappas, N. Smyth, N. Kociok, B. Kirchhof, M. Paulsson, V. Poulaki, and A. M. Joussen Overexpression of FasL in retinal pigment epithelial cells reduces choroidal neovascularization FASEB J, August 1, 2006; 20(10): 1689 - 1691. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Strauss The Retinal Pigment Epithelium in Visual Function Physiol Rev, July 1, 2005; 85(3): 845 - 881. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. D. Radtke, R. B. Aramant, M. J. Seiler, H. M. Petry, and D. Pidwell Vision Change After Sheet Transplant of Fetal Retina With Retinal Pigment Epithelium to a Patient With Retinitis Pigmentosa Arch Ophthalmol, August 1, 2004; 122(8): 1159 - 1165. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Zamiri, Q. Zhang, and J. W. Streilein Vulnerability of Allogeneic Retinal Pigment Epithelium to Immune T-Cell-Mediated Damage In Vivo and In Vitro Invest. Ophthalmol. Vis. Sci., January 1, 2004; 45(1): 177 - 184. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. V. Del Priore, O. Ishida, E. W. Johnson, Y. Sheng, D. B. Jacoby, L. Geng, T. H. Tezel, and H. J. Kaplan Triple Immune Suppression Increases Short-Term Survival of Porcine Fetal Retinal Pigment Epithelium Xenografts Invest. Ophthalmol. Vis. Sci., September 1, 2003; 44(9): 4044 - 4053. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Streilein Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation J. Leukoc. Biol., August 1, 2003; 74(2): 179 - 185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Hori, T. F. Ng, M. Shatos, H. Klassen, J. W. Streilein, and M. J. Young Neural Progenitor Cells Lack Immunogenicity and Resist Destruction as Allografts Stem Cells, July 1, 2003; 21(4): 405 - 416. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. K. Gipson, S. Spurr-Michaud, P. Argueso, A. Tisdale, T. F. Ng, and C. L. Russo Mucin Gene Expression in Immortalized Human Corneal-Limbal and Conjunctival Epithelial Cell Lines Invest. Ophthalmol. Vis. Sci., June 1, 2003; 44(6): 2496 - 2506. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. F. Ng, H. Osawa, J. Hori, M. J. Young, and J. W. Streilein Allogeneic Neonatal Neuronal Retina Grafts Display Partial Immune Privilege in the Subcapsular Space of the Kidney J. Immunol., November 15, 2002; 169(10): 5601 - 5606. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Gouras, J. Kong, and S. H. Tsang Retinal Degeneration and RPE Transplantation in Rpe65-/- Mice Invest. Ophthalmol. Vis. Sci., October 1, 2002; 43(10): 3307 - 3311. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A C Bateman, S M Turner, K S A Thomas, P R McCrudden, D R Fine, P A Johnson, C D Johnson, and J P Iredale Apoptosis and proliferation of acinar and islet cells in chronic pancreatitis: evidence for differential cell loss mediating preservation of islet function Gut, April 1, 2002; 50(4): 542 - 548. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Kanuga, H. L. Winton, L. Beauchene, A. Koman, A. Zerbib, S. Halford, P.-O. Couraud, D. Keegan, P. Coffey, R. D. Lund, et al. Characterization of Genetically Modified Human Retinal Pigment Epithelial Cells Developed for In Vitro and Transplantation Studies Invest. Ophthalmol. Vis. Sci., February 1, 2002; 43(2): 546 - 555. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Wang, D. S. Leonard, A. A. Castellarin, I. Tsukahara, Y. Ninomiya, F. Yagi, N. Cheewatrakoolpong, I. K. Sugino, and M. A. Zarbin Short-Term Study of Allogeneic Retinal Pigment Epithelium Transplants onto Debrided Bruch's Membrane Invest. Ophthalmol. Vis. Sci., November 1, 2001; 42(12): 2990 - 2999. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Cinatl Jr, S. Margraf, J.-U. Vogel, M. Scholz, J. Cinatl, and H. W. Doerr Human Cytomegalovirus Circumvents NF-{kappa}B Dependence in Retinal Pigment Epithelial Cells J. Immunol., August 15, 2001; 167(4): 1900 - 1908. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
